The Efficacy of Combining Platelet-rich Plasma With Crystallized Phenol in Pilonidal Sinus Disease

Launched by NECMI KADIOĞLU HOSPITAL · Mar 14, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new way to treat pilonidal sinus disease, which is a condition that can occur in the area near the tailbone. The researchers want to find out if combining a treatment called platelet-rich plasma (PRP) with a substance known as crystallized phenol can help patients heal faster and improve their treatment outcomes. Crystallized phenol has been used for years to treat this condition, but it often requires multiple visits to the doctor. By adding PRP, they hope to speed up the healing process.

The trial is looking for children and teenagers between the ages of 0 and 18 who have been diagnosed with pilonidal sinus disease. However, if a patient has already had surgery for this condition or has certain abnormalities in the area, they won't be able to join the study. Participants can expect to receive the new treatment and will have follow-up appointments to check on their progress. This research could help improve the way pilonidal sinus disease is treated in young patients, making the healing process quicker and more effective.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • The study will be included patients with pilonidal sinus disease aged between 0 to 18 years.
• Exclusion Criteria:
• • Patients who had undergone prior pilonidal sinus disease surgery or had anomalies in the sacrococcygeal region will be excluded from the study. Additionally, patients who will decline to participate in the study or will be failed to attend post-procedural outpatient follow-ups will also be excluded.